Hugh Griffith
Fortune : 327 600 $ au 31/03/2024
Fortune : 327 600 $ au 31/03/2024
Hugh Stephen Griffith was the founder of EdixoMed Ltd. (2011, Non-Executive Director), MedAnnex Ltd. (2009, Non-Executive Director), Thirty Holdings Ltd. (2018, Non-Executive Director), NuCana Plc (1997, Chief Executive Officer & Executive Director), and Alida Capital International Ltd. (2009, Chief Executive Officer & Director).
Former job at Ernco 200 LTD (2002, Executive Commercial Director), Abbott Laboratories (1995-2001, Manager-Business Development), Parke-Davis & Co. Ltd. (Principal), Warner Lambert (UK) Ltd. (1992-1995, Principal), and Bioenvision, Inc. (2002-2007, Chief Operating Officer).
Education at The University of Stirling (undergraduate) and Cardiff Business School (MBA).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUCANA PLC 3,96 % | 18/03/2026 | 1 260 000 ( 3,96 % ) | 327 600 $ | 31/03/2024 |
| Sociétés | Poste | Début |
|---|---|---|
| NUCANA PLC | Fondateur | 28/01/1997 |
| Sociétés | Poste | Fin |
|---|---|---|
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Fondateur | 01/01/2024 |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Fondateur | 25/09/2023 |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Fondateur | 01/01/2023 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Directeur des opérations | 01/12/2007 |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Corporate Officer/Principal | 01/09/2002 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy | Health Technology |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufacturer and wholesaler of pharmaceuticals and over the counter medicines | Health Technology |
The University of Stirling
The University of Stirling Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuCana Plc
NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Alida Capital International Ltd.
Alida Capital International Ltd. Investment ManagersFinance Provides capital and practical assistance for emerging biopharmaceutical companies | Finance |
Cardiff Business School
Cardiff Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Commercial Services |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national